PT2470202E - Toxinas clostrídicas para utilização no tratamento da ejaculação precoce - Google Patents

Toxinas clostrídicas para utilização no tratamento da ejaculação precoce Download PDF

Info

Publication number
PT2470202E
PT2470202E PT107429938T PT10742993T PT2470202E PT 2470202 E PT2470202 E PT 2470202E PT 107429938 T PT107429938 T PT 107429938T PT 10742993 T PT10742993 T PT 10742993T PT 2470202 E PT2470202 E PT 2470202E
Authority
PT
Portugal
Prior art keywords
premature ejaculation
clostridial toxins
treating premature
treating
clostridial
Prior art date
Application number
PT107429938T
Other languages
English (en)
Portuguese (pt)
Inventor
Gustavo M Gaxiola
Ivan E Aguilar
Gilberto P Paz
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of PT2470202E publication Critical patent/PT2470202E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT107429938T 2009-08-26 2010-08-10 Toxinas clostrídicas para utilização no tratamento da ejaculação precoce PT2470202E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/548,073 US8147848B2 (en) 2009-08-26 2009-08-26 Method for treating premature ejaculation with a botulinum neurotoxin

Publications (1)

Publication Number Publication Date
PT2470202E true PT2470202E (pt) 2014-02-24

Family

ID=43127150

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107429938T PT2470202E (pt) 2009-08-26 2010-08-10 Toxinas clostrídicas para utilização no tratamento da ejaculação precoce

Country Status (18)

Country Link
US (8) US8147848B2 (enExample)
EP (2) EP2708239B1 (enExample)
JP (2) JP5766699B2 (enExample)
KR (1) KR101612988B1 (enExample)
CN (2) CN103816530B (enExample)
AU (2) AU2010289969B2 (enExample)
BR (1) BR112012004246A2 (enExample)
CA (1) CA2772372C (enExample)
CY (1) CY1114792T1 (enExample)
DK (2) DK2470202T3 (enExample)
ES (2) ES2564677T3 (enExample)
IN (1) IN2012DN02210A (enExample)
MX (2) MX2012002378A (enExample)
PL (1) PL2470202T3 (enExample)
PT (1) PT2470202E (enExample)
RU (1) RU2568844C2 (enExample)
SI (1) SI2470202T1 (enExample)
WO (1) WO2011028371A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8147848B2 (en) 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
US20120251518A1 (en) * 2011-03-29 2012-10-04 Allergan, Inc. Endopeptidase Treatment of Sexual Dysfunction Disorders
US20130066148A1 (en) * 2011-09-12 2013-03-14 Kang Seon Cho Method of augmenting glans
EP2649985A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
EP2649983A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (II)
EP2649984A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis
JP6470678B2 (ja) 2012-04-13 2019-02-13 ルブリゾル アドバンスド マテリアルズ， インコーポレイテッド ニューロンの開口分泌を阻害する化合物（ｉｉ）
US9764010B2 (en) * 2012-08-24 2017-09-19 Allergan, Inc. Method for treating premature ejaculation with a neurotoxin
KR20170093780A (ko) * 2014-09-02 2017-08-16 아메리칸 실버, 엘엘씨 보툴리눔 톡신 및 콜로이드 은 입자
RU2565104C1 (ru) * 2014-10-24 2015-10-20 Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России) Способ лечения преждевременной эякуляции
MX2019013716A (es) * 2017-05-18 2020-10-12 Revance Therapeutics Inc Métodos de tratamiento para la distonía cervical.
WO2018220232A1 (en) * 2017-06-02 2018-12-06 Universite De Versailles-St Quentin En Yvelines Pharmaceutical combination product comprising botulinum toxin for the treatment of erectile dysfunction
US12102556B2 (en) 2022-05-31 2024-10-01 Max Azevedo System and method for fallopian birth control
US12337014B1 (en) 2024-06-17 2025-06-24 Enrico Guarino Intracavernosal gel infusion system with neurotoxin modulation for erectile function

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120306D0 (en) 1991-09-24 1991-11-06 Graham Herbert K Method and compositions for the treatment of cerebral palsy
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US5427291A (en) 1993-09-21 1995-06-27 Smith; David S. Ski carrier and method employing same
DE69434443T2 (de) 1993-12-28 2006-05-24 Allergan, Inc., Irvine Verwendung der neutrotoxischen Komponente des Botulinum Toxins zur Muskelschmerzbehandlung
US5766605A (en) 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
CN1123680A (zh) * 1994-11-18 1996-06-05 吕建京 一种对于肺脾肾虚有良好功效的保健品及其制造方法
ATE314085T1 (de) 1997-07-15 2006-01-15 Univ Colorado Verwendung von botulinumtoxin zur behandlung von harninkontinenz
US6063768A (en) * 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
US6593335B1 (en) 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
CN1146866C (zh) * 1998-11-17 2004-04-21 阿尔卑斯电气株式会社 浮起式磁头的冠顶形成方法及冠顶形成装置
FR2793689B1 (fr) 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
US20060216313A1 (en) * 1999-08-10 2006-09-28 Allergan, Inc. Methods for treating a stricture with a botulinum toxin
RU2180591C2 (ru) * 1999-12-24 2002-03-20 Государственное научное предприятие Московский научно-исследовательский институт психиатрии МЗ РФ Средство для лечения сексуальных дисфункций у мужчин
US6495154B1 (en) 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
US20020086036A1 (en) 2000-12-05 2002-07-04 Allergan Sales, Inc. Methods for treating hyperhidrosis
WO2002074241A2 (en) 2001-03-16 2002-09-26 Dmi Biosciences Inc. Method of delaying ejaculation
EP1373203A1 (en) 2001-03-29 2004-01-02 Bristol-Myers Squibb Company Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
US20030113349A1 (en) 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods
ATE406900T1 (de) * 2002-01-25 2008-09-15 Modular Properties Ltd Verfahren und zusammensetzungen zur behandlung der männlichen erektionsstörung
US6776991B2 (en) * 2002-06-26 2004-08-17 Allergan, Inc. Methods for treating priapism
US20040009180A1 (en) 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
TW200418838A (en) * 2002-09-18 2004-10-01 Bristol Myers Squibb Co Compounds for the treatment of premature ejaculation
US20070264373A1 (en) * 2004-01-26 2007-11-15 Ian Carroll Toxin Induced Sympathectomy
US20060100584A1 (en) 2004-08-10 2006-05-11 Orest Olejnik Needleless microprotrusion elastoplast system
US20080220021A1 (en) 2005-02-14 2008-09-11 Pankaj Modi Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
CN1682810A (zh) * 2005-02-22 2005-10-19 黄资源 一种治疗前列腺疾病的前列外敷散
SG160357A1 (en) 2005-03-03 2010-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
NZ568216A (en) 2005-11-17 2012-09-28 Revance Therapeutics Inc Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
US7445783B2 (en) 2006-10-30 2008-11-04 Cappellos, Inc. Topical and transdermal treatments using urea formulations
US20100150994A1 (en) 2006-12-01 2010-06-17 Anterios, Inc. Amphiphilic entity nanoparticles
US20090005319A1 (en) * 2007-07-01 2009-01-01 Barone Jr Frank V Topical compositions for delaying ejaculation and methods of using the same
US20090093547A1 (en) * 2007-10-09 2009-04-09 Sciele Pharma, Inc. Compositions and Methods for Treating Premature Ejaculation
WO2009055351A1 (en) 2007-10-23 2009-04-30 Allergan, Inc. Methods of treating urogenital-neurological disorders using modified clostridial toxins
US8147848B2 (en) 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
US9049616B2 (en) 2012-03-29 2015-06-02 Broadcom Corporation Session recovery after network coordinator or AP restart for single user, multiple user, multiple access, and/or MIMO wireless communications
US9764010B2 (en) 2012-08-24 2017-09-19 Allergan, Inc. Method for treating premature ejaculation with a neurotoxin

Also Published As

Publication number Publication date
ES2446969T3 (es) 2014-03-11
US20140140981A1 (en) 2014-05-22
US9907841B2 (en) 2018-03-06
AU2010289969A1 (en) 2012-03-22
HK1194292A1 (en) 2014-10-17
CY1114792T1 (el) 2016-12-14
CN102802663B (zh) 2014-03-19
US9186395B2 (en) 2015-11-17
JP2015163654A (ja) 2015-09-10
KR20120103760A (ko) 2012-09-19
JP5766699B2 (ja) 2015-08-19
SI2470202T1 (sl) 2014-02-28
US20170020997A1 (en) 2017-01-26
US20130059789A1 (en) 2013-03-07
US8916177B2 (en) 2014-12-23
AU2015213381A1 (en) 2015-09-03
US20160067319A1 (en) 2016-03-10
JP2013503165A (ja) 2013-01-31
EP2708239B1 (en) 2015-12-09
IN2012DN02210A (enExample) 2015-08-21
RU2012110324A (ru) 2013-10-10
PL2470202T3 (pl) 2014-05-30
MX349947B (es) 2017-08-22
HK1171658A1 (en) 2013-04-05
EP2708239A1 (en) 2014-03-19
CN103816530B (zh) 2016-12-07
US9457069B2 (en) 2016-10-04
ES2564677T3 (es) 2016-03-28
US8617570B2 (en) 2013-12-31
AU2015213381B2 (en) 2017-05-25
EP2470202B1 (en) 2013-12-18
CA2772372C (en) 2016-07-12
US20120148563A1 (en) 2012-06-14
US8329193B2 (en) 2012-12-11
US8147848B2 (en) 2012-04-03
US20150064167A1 (en) 2015-03-05
MX2012002378A (es) 2012-06-28
DK2708239T3 (en) 2016-03-14
JP6078108B2 (ja) 2017-02-08
CN103816530A (zh) 2014-05-28
WO2011028371A1 (en) 2011-03-10
US20180185460A1 (en) 2018-07-05
CA2772372A1 (en) 2011-03-10
RU2568844C2 (ru) 2015-11-20
KR101612988B1 (ko) 2016-04-15
EP2470202A1 (en) 2012-07-04
US20110052636A1 (en) 2011-03-03
CN102802663A (zh) 2012-11-28
DK2470202T3 (da) 2014-01-27
AU2010289969B2 (en) 2015-05-14
US10420823B2 (en) 2019-09-24
BR112012004246A2 (pt) 2016-04-05

Similar Documents

Publication Publication Date Title
PT2470202E (pt) Toxinas clostrídicas para utilização no tratamento da ejaculação precoce
ZA200903860B (en) Treatment of PRDC in pigs
ZA201203151B (en) Device for personal use in phototherapy
SMT202300433T1 (it) Peptide per l'uso nella prevenzione o nel trattamento della degenerazione maculare
GB2459508B (en) Surfactant for use in the production of modified sulphur
GB0917044D0 (en) Agents, uses and methods
GB0917054D0 (en) Agents, uses and methods
IL232090A (en) Preparations for use in the treatment of nephropathy
AP3315A (en) Detoxification with reducing agents
EP2404592A4 (en) HAIR TREATMENT COMPOSITION
ZA201105125B (en) Hair treatment composition
SI2621517T1 (sl) Sestavek za uporabo pri zdravljenju neplodnosti
ZA201201116B (en) Hair treatment composition
EP2512504A4 (en) COMPOSITION AND THERAPEUTIC METHOD
GB0901465D0 (en) Compounds for use in therapy
PL2263454T3 (pl) Kompozycja uzdatniająca
GB0917454D0 (en) Improvements in and relating to thermostats
ZA201206853B (en) Composition for use in water treatment
IL220241A0 (en) Use of transferrin in treatment of beta-thalassemias
PL2229943T3 (pl) Związek do zastosowania w leczeniu neuropatii obwodowych
GB0901891D0 (en) Improvements in or relating to body wear
GB0910889D0 (en) Improvements in or relating to treatment tables
ZA201106171B (en) Fabric treatment composition and method
GB0806909D0 (en) Improved process for deliming in leather-making
GB0904792D0 (en) Improvements in or relating to waste treatment